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Cédric Blanpain
Stem cells in development and disease 
Cédric Blanpain received his MD/PhD from the University of Brussels, Belgium. His interest in stem cells (SCs) began during 
his postdoctoral work with Elaine Fuchs at The Rockefeller University, where he developed a new method to isolate hair 
follicle SCs and demonstrated their multipotency. He also delineated the role of Wnt and Notch signaling pathways in 
regulating skin SCs. He is now an investigator of the research institute WELBIO (Walloon Excellence in Life Science and 
Biotechnology) and a researcher of the National Research Scientific Fund (FNRS) at the University of Brussels. His laboratory 
is studying the role of SCs during development, homeostasis, and cancer. His group has identified the earliest cardiovascular 
progenitors and the mechanism of their specification during embryonic stem cell differentiation, the cellular origin of touch cells, the sensitivities of 
different epidermal cell populations to DNA damage, and the cellular origin of the two most frequent skin cancers. Photo courtesy of frédérique semet.
Titia de Lange
Telomere biology 
Titia de Lange is the Leon Hess Professor at The Rockefeller University in New York. She obtained a PhD in biochemistry at the 
University of Amsterdam working on trypanosome antigenic variation with Piet Borst and did postdoctoral work with Harold 
Varmus at UCSF. Her current research focuses on how telomeres solve the end-protection problem. Her laboratory identified a 
six-subunit protein complex, termed shelterin, that binds to human and mouse telomeres and protects chromosome ends. She 
uses a combination of cell biological and biochemical approaches in mouse knockout models to dissect the mechanism by 
which shelterin represses checkpoint activation and prevents DNA repair at chromosome ends. Photo courtesy of Zach Veilleux.
Ivan Dikic
Ubiquitin and autophagy signaling networks 
Ivan Dikic grew up in Croatia, where he trained as a medical doctor. He obtained his PhD in molecular biology from the 
University of Zagreb while working under the supervision of Joseph Schlessinger at New York University Medical Center. He 
is currently a Professor at Goethe University Medical School and Director of the Frankfurt Institute for Molecular Life Sciences 
in Frankfurt, Germany. His research focuses on the role of ubiquitin (Ub), a small protein that is posttranslationally and 
covalently attached to thousands of cellular proteins. His pioneering work led to the demonstration that Ub acts as a multivalent 
cellular signal recognized by an expanding number of Ub-binding proteins that in turn translate this molecular signal into 
appropriate cellular phenotypes. His group identified several novel Ub-binding domains and used structural and functional 
studies to demonstrate their roles in the regulation of DNA repair, inflammation, receptor endocytosis, and proteasomal degradation. He has recently 
described mechanisms by which linear ubiquitination can regulate the NF-B pathway and apoptosis. His current interests focus on selective autophagy, 
which is essential for the clearance of protein aggregates, pathogens, and damaged mitochondria from the cell. Photo courtesy of fmls.
At JCB, active scientists direct the peer review of all submitted 
manuscripts, ensuring the highest standards for quality, timeli-
ness, and relevance to the field of our published papers. We ap-
preciate all of our Board members’ efforts and commitment to 
the cell biology community. Their experience and passion for 
cell biology ensures that submitted manuscripts are in the best 
possible hands during the editorial process.
To adapt to changes in submission numbers in particular 
fields and to the emergence of new areas of cell biology, we 
periodically adjust the composition of our Editorial Board. 
We here announce—and welcome—three new members of 
the JCB Editorial Board. We look forward to working with 
them in the years ahead.
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